Heghine Khachatryan: New Insights on Thrombosis in BCR-ABL1 Negative Myeloproliferative Neoplasms
Heghine Khachatryan, Editor-in-Chief of Hemostasis Today, Head of Hemophilia and Thrombosis Center at Yeolyan Hematology and Oncology Center, shared Journal of Thrombosis and Haemostasis (JTH)’s post on LinkedIn, adding:
“New insights into thrombosis in BCR::ABL1-negative myeloproliferative neoplasms
Thrombosis remains the leading cause of morbidity and mortality in patients with Philadelphia chromosome–negative myeloproliferative neoplasms (MPNs).
Understanding the molecular mechanisms underlying thrombotic risk is essential for improving both risk stratification and targeted therapeutic approaches.
A recent study published in the Journal of Thrombosis and Haemostasis demonstrates that dysregulation of HIF-1α–regulated and thromboinflammatory genes is associated with an increased thrombotic risk in patients with BCR::ABL1-negative MPNs.
In a cohort of 120 patients, increased expression of genes including SLC2A1 and SELP correlated with a history of thrombosis, supporting the concept that hypoxia signaling and thromboinflammation are integral components of MPN pathobiology.
These findings reinforce the growing evidence that thrombotic risk in MPN extends beyond conventional clinical predictors and is closely linked to molecular and inflammatory pathways.
Identification of such biomarkers may facilitate more precise risk assessment and contribute to the development of novel targeted therapeutic strategies.”
Journal of Thrombosis and Haemostasis (JTH) shared a post on LinkedIn about a recent article by Olga Morath et al., adding:
“Dysregulation of HIF-1α–regulated and thromboinflammatory genes may contribute to thrombotic risk in patients with BCR::ABL1-negative myeloproliferative neoplasms
In 120 MPN patients, SLC2A1 and SELP gene expression were independently linked to thrombosis, with higher expression in JAK2-mutated patients suggesting a JAK2–HIF pathway connection.”
Title: Dysregulation of HIF-1α–regulated and thromboinflammatory genes may contribute to thrombotic risk in patients with BCR::ABL1-negative myeloproliferative neoplasms
Authors: Olga Morath, Therese Wolfrum, Carl Crodel, Andreas Hochhaus, Thomas Ernst, Jenny Rinke
Other posts featuring Heghine Khachatryan on Hemostasis Today.
-
Aug 23, 2026, 17:51Gurpreet Kaurr: A Proud Milestone in Haematology and Oncology
-
Aug 23, 2026, 17:33Kathrine Kaspersen: How Voluntary Plasma Donors Helped Transform Denmark’s Plasma Supply
-
Aug 23, 2026, 16:51Sthanu Subramanian: Empagliflozin and a Rise in Hematocrit
-
Aug 23, 2026, 16:50Lale Tokgözoğlu: New PCSK9i Research Published in the European Heart Journal
-
Aug 23, 2026, 16:44Eric Gehrie: Your 2026 Guide to the Essentials of Transfusion Medicine
-
Aug 23, 2026, 16:35Thomas Dayspring: The Overlooked Pathway in Cholesterol Homeostasis
-
Aug 23, 2026, 16:28Evan Mapelu: The People Who Make Cancer Care Meaningful
-
Aug 23, 2026, 16:09Felice Gragnano: New Publication on Aspirin Discontinuation After PCI for Acute Coronary Syndromes
-
Aug 23, 2026, 16:06Mostafa Faisal: Donor Type and Long-Term Quality of Life After HCT for Severe Aplastic Anemia